Breaking News Instant updates and real-time market news.

DCPH

Deciphera

$19.91

-3.57 (-15.20%)

06:55
08/13/19
08/13
06:55
08/13/19
06:55

Deciphera Pharmaceuticals trading halted, news pending

DCPH Deciphera
$19.91

-3.57 (-15.20%)

03/14/19
PIPR
03/14/19
NO CHANGE
Target $50
PIPR
Overweight
Deciphera development of ripretinib 'progressing nicely', says Piper Jaffray
Piper Jaffray analyst Christopher Raymond kept his Overweight rating and $50 price target on Deciphera after its in-line Q4 results, saying the company's development of ripretinib is progressing nicely with ongoing phase 3 enrollment in INTRIGUE study and results for INVICTUS study expected later this year. The analyst remains positive on the shares given the company's "catalyst-rich" second half of the year on tap.
06/03/19
PIPR
06/03/19
NO CHANGE
Target $55
PIPR
Overweight
Deciphera price target raised to $55 from $50 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond raised his price target for Deciphera Pharmaceuticals (DCPH) to $55 from $50 after hosting investor meetings with management and reviewing competitor Blueprint Medicines' (BPMC) avapritinib update over the weekend. Given the "significant" valuation-gap between the two companies, driven by misperceptions around their respective KIT inhibitors, new money investment into Deciphera "right here makes a lot of sense," Raymond tells investors in a research note. He keeps an Overweight rating on the shares.
06/10/19
PIPR
06/10/19
NO CHANGE
Target $55
PIPR
Overweight
Piper Jaffray says a buyer of Deciphera after DCC-3116 added to pipeline
Piper Jaffray analyst Christopher Raymond maintained an Overweight rating and $55 price target on Deciphera following the disclosure of the company's newest preclinical candidate, DCC-3116, an ULK kinase inhibitor important in autophagy initiation. In a research note to investors, Raymond says that given recent advances in KRAS targeting, this target's complementary effects make it an "intriguing" combination agent with the myriad agents approved and in development, adding that he remains a buyer.
07/18/19
DBAB
07/18/19
INITIATION
Target $42
DBAB
Buy
Deciphera initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Konstantinos Aprilakis started Deciphera with a Buy rating and $42 price target. The analyst initiated coverage on eight smid-cap Biotechnology stocks in the oncology space.

TODAY'S FREE FLY STORIES

TRHC

Tabula Rasa HealthCare

$64.93

1.38 (2.17%)

08:03
08/22/19
08/22
08:03
08/22/19
08:03
Hot Stocks
Tabula Rasa HealthCare announces partnership with Bainbridge Health Partners »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

MYL

Mylan

$19.07

-0.02 (-0.10%)

, NVO

Novo Nordisk

$51.82

0.54 (1.05%)

08:02
08/22/19
08/22
08:02
08/22/19
08:02
Periodicals
Novo Nordisk sues Mylan for alleged patent infringement, Reuters reports »

Mylan (MYL) has been sued…

MYL

Mylan

$19.07

-0.02 (-0.10%)

NVO

Novo Nordisk

$51.82

0.54 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 25

    Sep

TREX

Trex Company

$85.68

-0.085 (-0.10%)

08:01
08/22/19
08/22
08:01
08/22/19
08:01
Initiation
Trex Company initiated  »

Trex Company initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

AFL

Aflac

$48.98

-2.88 (-5.55%)

08:00
08/22/19
08/22
08:00
08/22/19
08:00
Hot Stocks
Aflac says not anticipating any disruption in long-term JPH Alliance plans »

Aflac said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$30.14

4.165 (16.04%)

08:00
08/22/19
08/22
08:00
08/22/19
08:00
Options
Pinduoduo call buyer realizes 21% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
08/22/19
08/22
08:00
08/22/19
08:00
General news
Treasury Market Outlook: yields are higher »

Treasury Market Outlook:…

AFL

Aflac

$48.98

-2.88 (-5.55%)

07:59
08/22/19
08/22
07:59
08/22/19
07:59
Hot Stocks
Aflac says 'rigorous, voluntary review' of postal channel sales began in July »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:53
08/22/19
08/22
07:53
08/22/19
07:53
Conference/Events
Citigroup to hold a forum »

Citi-REITAS-SGX C-Suite…

JEC

Jacobs Engineering

$86.06

2.45 (2.93%)

07:51
08/22/19
08/22
07:51
08/22/19
07:51
Hot Stocks
Jacobs Engineering appointed as smart meter specialist in Singapore »

Jacobs has been appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSGN

MSG Networks

$14.78

-2.07 (-12.28%)

07:51
08/22/19
08/22
07:51
08/22/19
07:51
Recommendations
MSG Networks analyst commentary  »

MSG Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$71.77

0.44 (0.62%)

07:50
08/22/19
08/22
07:50
08/22/19
07:50
Upgrade
Cerner rating change  »

Cerner upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

ADMA

ADMA Biologics

$4.05

-0.01 (-0.25%)

07:50
08/22/19
08/22
07:50
08/22/19
07:50
Hot Stocks
ADMA Biologics announces commercial relaunch of BIVIGAM »

ADMA Biologics announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

FLWS

1-800-Flowers.com

$19.36

0.74 (3.97%)

07:48
08/22/19
08/22
07:48
08/22/19
07:48
Earnings
1-800-Flowers.com sees FY20 EPS up 8%-10% »

Sees FY20 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

FLWS

1-800-Flowers.com

$19.36

0.74 (3.97%)

07:48
08/22/19
08/22
07:48
08/22/19
07:48
Earnings
1-800-Flowers.com reports Q4 adj. EPS (12c), consensus (14c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 25

    Sep

SQM

SQM

$25.40

-0.86 (-3.27%)

07:45
08/22/19
08/22
07:45
08/22/19
07:45
Downgrade
SQM rating change  »

SQM downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

SEDG

SolarEdge

$87.87

3.16 (3.73%)

07:44
08/22/19
08/22
07:44
08/22/19
07:44
Downgrade
SolarEdge rating change  »

SolarEdge downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$84.51

2.27 (2.76%)

07:43
08/22/19
08/22
07:43
08/22/19
07:43
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:42
08/22/19
08/22
07:42
08/22/19
07:42
Hot Stocks
Dick's Sporting reports Q2 eCommerce sales up 21% »

eCommerce penetration for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

FLR

Fluor

$17.35

0.3 (1.76%)

07:41
08/22/19
08/22
07:41
08/22/19
07:41
Upgrade
Fluor rating change  »

Fluor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:40
08/22/19
08/22
07:40
08/22/19
07:40
Hot Stocks
Dick's Sporting up 10% after Q2 results beat estimates, FY19 profit view raised »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PDD

Pinduoduo

$30.14

4.165 (16.04%)

07:39
08/22/19
08/22
07:39
08/22/19
07:39
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:38
08/22/19
08/22
07:38
08/22/19
07:38
Earnings
Dick's Sporting says FY19 EPS guidance includes expected tariff impacts »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TGT

Target

$103.11

17.54 (20.50%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Recommendations
Target analyst commentary  »

Target valuation remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Hot Stocks
Dick's Sporting CEO says 'we are very pleased with our second quarter results' »

"We are very pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HMSY

HMS Holdings

$38.69

-0.19 (-0.49%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Downgrade
HMS Holdings rating change  »

HMS Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.